Journal profile · PHARMACOLOGY & PHARMACY
Asian Journal of Pharmaceutical Research and Health Care
ISSN 2250-1444 · eISSN 2250-1460
Asian Journal of Pharmaceutical Research and Health Care: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.3 (journal website); fully open access; median 126 days to acceptance (100 articles, last 24 months); 62 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
Asian Journal of Pharmaceutical Research and Health Care is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Methods in Pharmaceuticals, Drug Solubulity and Delivery Systems and Natural Antidiabetic Agents Studies, together about 22.4% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The aim of this study was to understand the pharmacodynamic and pharmacokinetic interactions of topiramate on gliclazide action in rodents and nonrodents.
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Akondi Butchi RajuPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Analytical Methods in PharmaceuticalsChemistry8.9%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.2%
- Natural Antidiabetic Agents StudiesMedicine6.3%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.2%
- COVID-19 and Mental HealthPsychology4.9%
- Analytical Chemistry and ChromatographyChemistry4.6%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics4.6%
- Ethnobotanical and Medicinal Plants StudiesAgricultural and Biological Sciences4.3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCILetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 0.3Publisher website ·
- h-index
- 17OpenAlex ·
- i10-index
- 29OpenAlex ·
- 2-year mean citedness
- 0.56OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 62LetPub ·
Articles by year OpenAlex count · 512 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 30 | 30 | 1 |
| 2025 | 62 | 62 | 21 |
| 2024 | 66 | 66 | 66 |
| 2023 | 61 | 61 | 78 |
| 2022 | 39 | 39 | 54 |
| 2021 | 26 | 26 | 63 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
126 daysMedian, submission to acceptance · P25–P75 88 days – 188 days
- Acceptance to online
- median 55 days (100 articles)
- Submission to online
- median 197 days
- Sample
- 100 articles with submission and acceptance dates (110 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- ISSN
- 2250-1444
- Electronic ISSN
- 2250-1460
- Latest issue on the website
- Volume 18, Issue 2 (June 2026)
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Asian Journal of Pharmaceutical Research and Health Care
What CAS zone is Asian Journal of Pharmaceutical Research and Health Care in?
In the 2025 upgraded edition of the CAS Journal Ranking, Asian Journal of Pharmaceutical Research and Health Care is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Asian Journal of Pharmaceutical Research and Health Care?
The journal's website gives an impact factor of 0.3; this is the journal's own figure, as LetPub lists none for it; h-index 17.
How long does peer review take at Asian Journal of Pharmaceutical Research and Health Care?
Based on the dates recorded on 100 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 126 days (interquartile range 88–188 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Asian Journal of Pharmaceutical Research and Health Care?
According to LetPub and DOAJ records, Asian Journal of Pharmaceutical Research and Health Care is indexed in ESCI.
Is Asian Journal of Pharmaceutical Research and Health Care open access, and what is the APC?
Asian Journal of Pharmaceutical Research and Health Care is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .